Advertisement
Screener

CERO THERAPEUTICS HOLDINGS, INC. (CERO) Other Nonoperating Expense

2.8 / 5 stars · 68/120 Roast Me

CERO THERAPEUTICS HOLDINGS, INC. Other Nonoperating Expense

CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Other Nonoperating Expense of $630.77 thousand for the 3-month period ending 2024-06-30, per its 10-Q filed 2025-08-22.

Financial Statements › Income Statement › Other Income

us-gaap:OtherNonoperatingExpense · last filed 2025-08-22

  • CERO THERAPEUTICS HOLDINGS, INC. other nonoperating expense for the quarter ending 2024-06-30 was $630.77K.
Period endOther Nonoperating Expense 3 monthOther Nonoperating Expense 5 month
2024-06-30$630.77K
10-Q · filed 2025-08-22
$630.77K
10-Q · filed 2025-08-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
AIM ImmunoTech Inc. (AIM)United States$0.006B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
VivoSim Labs, INC. (VIVS)United States$0.003B
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
IN8BIO, INC. (INAB)United States$0.012B-0.76
CURIS INC (CRIS)United States$0.002B-0.05